Le Lézard
Classified in: Science and technology, Business
Subject: AWD

CSIA Awards Vertech 2022 Integrator of the Year

The Control System Integrators Association named Vertech the 2022 Integrator of the Year at the annual CSIA Executive Conference.

PHOENIX, July 1, 2022 /PRNewswire-PRWeb/ -- Vertech is proud to announce that we have received the 2022 Integrator of the Year Award by CSIA. This award recognizes Vertech's commitment to advancing our industry by designing innovative industrial automation solutions that improve productivity and are a joy to use.

President Titus Crabb founded Vertech 18 years ago with the vision to build a team that does masterful work while treating each other with dignity and respect. He commented, "We have attracted an amazing, talented team of people that believe in that vision. We love what we do, and we love that we can inspire each other to grow professionally and personally."

But rather than talk more about Vertech, he had a few encouraging words to fellow integrators. "What we do as integration companies is world-changing! ... The increased standard of living, longer life expectancy, and reduced suffering of humans in this world has been monumental thanks in large part to technological advancement. Companies like ours enable these improvements, and the advancements we will help bring to life in the years to come will have a massive positive impact in our world."

The team at Vertech is thankful for the support and guidance of organizations like CSIA that support integrators in this work. Ashley Buckmaster, Director of Finance and Administration, said, "CSIA has been a great guide to the continuous improvement of Vertech's best practices... With the guidance that CSIA provides, our procedures have continued to get stronger and more well-documented. The practices that we have adopted from CSIA have helped us grow in a strategic and structured fashion."

Clyde Pace, Director of Project Management agreed, "I'm very grateful to CSIA for their commitment and education on the fundamentals of running a successful business in our industry."

With this in mind, integrators can make an even greater difference beyond providing excellent, reliable technology to solve today's problems. Vertech's President stated, "It occurred to me recently that... the lasting impact Vertech will make is not our control systems. Our mission is the positive influence we have on the lives of the people we work with including our employees, our clients, our vendor partners, and their families... I encourage you to continue embracing that responsibility in your organizations and leave a positive impact on this world that will never require an upgrade."

We would like to thank CSIA for this recognition, and we look forward to continuing to work together to advance the control system integration industry.

CSIA is a not-for-profit, global trade association that seeks to advance the industry of control system integration. CSIA helps members improve their business skills, provides a forum to share industry expertise, and promotes the benefits of hiring a certified control system integrator. CSIA has more than 500 member companies in 35 countries and hosts the Industrial Automation Exchange.

Media Contact

Thea Sander, Vertech, +1 480-604-2076, [email protected]



SOURCE Vertech

These press releases may also interest you

at 21:05
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound...

at 21:00
LG Electronics USA announced today the 2022 lineup of TONE Free® true wireless earbuds. The new models provide the ultimate sound experience with advanced audio technologies, a better-fitting design, and a host of useful, new features. The new TONE...

at 20:30
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA"). Malignant glioma has...

at 20:10
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a...

at 20:00
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...

News published on 1 july 2022 at 13:00 and distributed by: